DXN Herbal Manufacturing (India) Pvt. Ltd. Vs ITO (Madras High Court)
The case of DXN Herbal Manufacturing (India) Pvt. Ltd. vs. ITO before the Madras High Court involved a dispute over tax deductions claimed under Sections 80IB and 43B of the Income Tax Act for the assessment years 2003-04 and 2004-05. The company, engaged in Ayurvedic drug manufacturing, sought tax deductions, but the Income Tax Department denied the claims, asserting that the company was engaged in mere trading rather than manufacturing. The Income Tax Appellate Tribunal (ITAT) upheld this decision, stating that filling mushroom powder into gelatin capsules did not constitute manufacturing, as the substance remained unchanged. The Tribunal ruled that no new product was created and denied the Section 80IB claim. Furthermore, the Tribunal dismissed the company’s claim for excise duty payment deductions under Section 43B, arguing that the payment was recorded as an advance in its accounts rather than an expense. The company appealed, arguing that the excise duty was a crystallized liability and should be deductible.
The Madras High Court reviewed various factors, including the statutory licenses held by DXN Herbal, quality control processes, and approvals from regulatory bodies. It found that the company had obtained a factory license and complied with regulatory conditions for Ayurvedic drug manufacturing. The court also considered Supreme Court precedents on defining “manufacture” and held that encapsulation involved significant transformation, making it eligible for deduction under Section 80IB. Additionally, it ruled that the excise duty payments were allowable under Section 43B, as they had been made in the relevant assessment year. The court relied on prior judgments where similar deductions were allowed for later years. Ultimately, the High Court overturned the ITAT ruling, recognizing DXN Herbal’s activities as manufacturing and granting the requested tax deductions.
